颈动脉内膜中层厚度的变化能否作为心血管疾病风险指标?尚待商榷
Cite this article as: Bots ML, den Ruijter HM. Variability in the intimamedia thickness measurement as marker for cardiovascular risk? Not quite settled yet. Cardiovasc Diagn Ther 2012;2:3-5. DOI: 10.3978/ j.issn.2223-3652.2012.01.06
Editorial

颈动脉内膜中层厚度的变化能否作为心血管疾病风险指标?尚待商榷

Michiel L. Bots, Hester M. den Ruijter

From Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands

Conflict of interest: Dr Bots has received over the years grants were obtained from Astra-Zeneca, Dutch Heart Foundation, Organon, Pfizer, Servier, The Netherlands Organisation for Health Research and Development, and TNO-Zeist, and consultancy fees from Astra-Zeneca, Boeringher, Organon, Pfizer, Servier, Schering-Plough, and Unilever. He runs the Vascular Imaging Center in Utrecht, a core laboratory for CIMT measurements in national and international observational and intervention studies.

Corresponding to:
Michiel L. Bots, MD, PhD. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6.131, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Tel: 0031 88 755 9305; Fax: 0031 88 755 5485. Email: m.l.bots@umcutrecht.nl.
Tel: 0031 88 755 9305; Fax: 0031 88 755 5485. Email: m.l.bots@umcutrecht.nl.

摘要:

颈动脉内膜中层厚度(CIMT)的测量已用于心血管研究二十年有余,并有充足证据显示了该测量的重要性。然而,颈动脉内膜中层增厚只是个体脉管系统情况的反映,并不能直接由此判断其会引发心肌梗死或中风。内膜中层厚度随时间推移的变化率也同样反映了动脉粥样硬化的进展情况。故这两项颈动脉内膜中层厚度测量指标都能反映心血管疾病的风险。

Cardiovasc Diagn Ther 2012;2:3-5. DOI: 10.3978/j.issn.2223-3652.2012.01.06

Download Citation